Integration of cervical screening in family planning clinics

International Journal of Gynecology and Obstetrics

Volumn 81, Issue 1, 2003, Pages 103-108

  Claeys, P ^a   De Vuyst, H ^a   Mzenge, G ^b   Sande, J ^c   Dhondt, V ^d   Temmerman, M ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Family Planning Association of Kenya   (Kenya)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Cervical cancer; Family Planning clinics; Integration

Indexed keywords

ADULT; AGE; ARTICLE; CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER SCREENING; CONTROLLED STUDY; FAMILY PLANNING; FEMALE; HIGH RISK PATIENT; HUMAN; INTEGRATION; INTERVIEW; MAJOR CLINICAL STUDY; MORBIDITY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY;

EID: 0037382132     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(03)00038-9     Document Type: Article

References (12)

1. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 80:(6):1999;827-841.
2. Laara E., Day N.E., Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet. 1:(8544):1987;1247-1249.
3. Bishop A., Wells E., Sherris J., Tsu V., Crook B. Cervical cancer: evolving prevention strategies for developing countries. Reprod Health Matters. 6:1995;60-70.
4. Sankaranarayanan R., Budukh A.M., Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Org. 79:(10):2001;954-962.
5. Gichangi P., De Vuyst H., Estambale B., Rogo K., Bwayo J., Temmerman M. HIV and cervical cancer in Kenya. Int J Gynecol Obstet. 76:(1):2002;55-63.
6. Miller A.B. Cervical cancer screening programmes: managerial guidelines. 1st ed: 1992;WHO, Geneva.
7. Rogo K.O., Omany J., Onyango J.N., Ojwang S.B., Stendahl U. Carcinoma of the cervix in the African setting. Int J Gynecol Obstet. 33:(3):1990;249-255.
8. Control of cancer of the cervix uteri. A WHO meeting. Bull World Health Org. 64:(4):1986;607-618.
9. Miller A.B. The (in)efficiency of cervical screening in Europe. Eur J Cancer. 38:(3):2002;321-326.
10. de Wolf C.J.M. Implementation and evaluation of cervical cancer screening programmes in the European Union. Franco E., Monsonego J. New developments in cervical cancer screening and prevention. I:1997;203-208 Blackwell Science Ltd, Oxford.
11. Moreno V., Bosch F.X., Munoz N., Meijer C.J., Shah K.V., Walboomers J.M., et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet. 359:(9312):2002;1085-1092.
12. Stewart F.H., Harper C.C., Ellertson C.E., Grimes D.A., Sawaya G.F., Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence. J Am Med Assoc. 285:(17):2001;2232-2239.